Manson Unit, Médecins Sans Frontières, London, United Kingdom.
PLoS One. 2013 Aug 14;8(8):e71407. doi: 10.1371/journal.pone.0071407. eCollection 2013.
In Lagos, Nigeria, Médecins Sans Frontières (MSF) and the Ministry of Health (MoH) commenced free antiretroviral treatment (ART) in a hospital-based clinic. We performed a cross-sectional study to compare factors associated with raised viral load between patients with ("experienced") and without ("naïve") prior antiretroviral (ARV) exposure at commencement of ART at the clinic. We also examined factors influencing ARV adherence in experienced patients prior to clinic entry.
We included adult patients receiving ART from MSF who answered a questionnaire about previous antiretroviral use. Multivariate logistic regression was used to estimate odds ratios (OR) for raised viral load (≥1000 copies/mL).
1246 (96%) patients answered: 1075 (86%) reported no, and 171 (14%) some, prior ARV exposure. ARV-naïve patients were more immunosuppressed at baseline: 65% vs 37% (p<0.001) had CD4<200; 17% vs 9% (p = 0.013) were WHO stage 4. Proportionately more experienced than naïve patients had raised viral loads (20% vs 9%, p<0.001) on ART in the MSF/MoH clinic. Raised viral load was associated with prior ARV experience (adjusted OR = 3.74, 95%CI 2.09-6.70, p<0.001) and complete interruption of current ART (adjusted OR = 3.71, 95%CI 2.06-6.68, p<0.001). Higher CD4 at time of VL and a higher self-rated score of recent adherence were associated with lower OR of a raised viral load. Among experienced patients who missed pills before joining MSF/MoH, most common reasons were because ARVS were not affordable (58%) or available (33%), with raised viral load associated with being unsure how to take them (OR = 3.16, 95%CI 1.10-9.12, p = 0.033).
Patients previously exposed to ARVs had increased OR of raised viral load. The cost and availability of ARVs were common reasons for missing ARVs before joining the MSF/MoH clinic, and inadequate patient knowledge was associated with raised viral load.
在尼日利亚拉各斯,无国界医生组织(MSF)和卫生部(MoH)在一家医院诊所开始提供免费抗逆转录病毒治疗(ART)。我们进行了一项横断面研究,比较了在诊所开始 ART 时,有(“经验丰富”)和没有(“无经验”)先前抗逆转录病毒(ARV)暴露的患者中,与病毒载量升高相关的因素。我们还研究了在进入诊所之前,有经验的患者中影响 ARV 依从性的因素。
我们纳入了从 MSF 接受 ART 的成年患者,他们回答了一份关于先前使用抗逆转录病毒药物的问卷。多变量逻辑回归用于估计病毒载量升高(≥1000 拷贝/ml)的比值比(OR)。
1246 名(96%)患者回答了问题:1075 名(86%)报告没有,171 名(14%)有一些先前的 ARV 暴露。无 ARV 经验的患者在基线时免疫抑制更严重:65%与 37%(p<0.001)的 CD4<200;17%与 9%(p=0.013)的 WHO 分期 4。在 MSF/MoH 诊所中,经验丰富的患者与无经验的患者相比,ART 后病毒载量升高的比例更高(20%与 9%,p<0.001)。病毒载量升高与先前的 ARV 经验(调整后的 OR=3.74,95%CI 2.09-6.70,p<0.001)和当前 ARV 治疗的完全中断(调整后的 OR=3.71,95%CI 2.06-6.68,p<0.001)相关。VL 时较高的 CD4 和自我评估的近期依从性评分较高与病毒载量升高的 OR 较低相关。在加入 MSF/MoH 之前漏服 ARV 的有经验的患者中,最常见的原因是 ARV 无法负担(58%)或无法获得(33%),而不确定如何服用这些药物与病毒载量升高相关(OR=3.16,95%CI 1.10-9.12,p=0.033)。
以前接触过 ARV 的患者病毒载量升高的 OR 增加。在加入 MSF/MoH 诊所之前,ARV 的费用和可及性是漏服 ARV 的常见原因,而患者知识不足与病毒载量升高有关。